Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Intratumoral virotherapy with 4-1BBL armed modified vaccinia Ankara eradicates solid tumors and promotes protective immune memory
Authors
Keywords
-
Journal
Journal for ImmunoTherapy of Cancer
Volume 9, Issue 2, Pages e001586
Publisher
BMJ
Online
2021-02-13
DOI
10.1136/jitc-2020-001586
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vitiligo: Mechanisms of Pathogenesis and Treatment
- (2020) Michael L. Frisoli et al. Annual Review of Immunology
- Intratumoral expression of IL-7 and IL-12 using an oncolytic virus increases systemic sensitivity to immune checkpoint blockade
- (2020) Shinsuke Nakao et al. Science Translational Medicine
- Cellular cytotoxicity is a form of immunogenic cell death
- (2020) Luna Minute et al. Journal for ImmunoTherapy of Cancer
- Broad Antibody and Cellular Immune Response from a Phase 2 Clinical Trial with a Novel Multivalent Poxvirus Based RSV Vaccine
- (2020) Elke Jordan et al. JOURNAL OF INFECTIOUS DISEASES
- Oncolytic viruses: how “lytic” must they be for therapeutic efficacy?
- (2019) Maria Eugenia Davola et al. OncoImmunology
- Lymph node conduits transport virions for rapid T cell activation
- (2019) Glennys V. Reynoso et al. NATURE IMMUNOLOGY
- Randomized clinical trial examining safety and immunogenicity of heterologous prime-boost Ebola vaccines, Ad26.ZEBOV and MVA-BN-Filo: 12-month data from Uganda and Tanzania
- (2019) Zacchaeus Anywaine et al. JOURNAL OF INFECTIOUS DISEASES
- A Phase 1 Dose Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules
- (2019) Margaret E Gatti-Mays et al. CLINICAL CANCER RESEARCH
- Tumor-localized costimulatory T cell engagement by the 4-1BB/HER2 bispecific antibody-Anticalin fusion PRS-343
- (2019) Marlon J Hinner et al. CLINICAL CANCER RESEARCH
- Optimization of 4-1BB antibody for cancer immunotherapy by balancing agonistic strength with FcγR affinity
- (2019) Xinyue Qi et al. Nature Communications
- Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen
- (2019) Stefanie K. Wculek et al. Journal for ImmunoTherapy of Cancer
- Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
- (2019) Christina Claus et al. Science Translational Medicine
- Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox
- (2019) Phillip R. Pittman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic cancer immunotherapy combines MVA-CD40L induced innate and adaptive immunity with tumor targeting antibodies
- (2019) José Medina-Echeverz et al. Nature Communications
- Transposable element expression in tumors is associated with immune infiltration and increased antigenicity
- (2019) Yu Kong et al. Nature Communications
- Oncolytic Viruses as Antigen-Agnostic Cancer Vaccines
- (2018) Stephen J. Russell et al. CANCER CELL
- Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27–Dependent Pathway
- (2018) Todd Bartkowiak et al. CLINICAL CANCER RESEARCH
- T Cells in Nonlymphoid Tissues Give Rise to Lymph-Node-Resident Memory T Cells
- (2018) Lalit K. Beura et al. IMMUNITY
- The function and dysfunction of memory CD8+ T cells in tumor immunity
- (2018) James L. Reading et al. IMMUNOLOGICAL REVIEWS
- Immunogenicity and safety of three consecutive production lots of the non replicating smallpox vaccine MVA: A randomised, double blind, placebo controlled phase III trial
- (2018) Edgar Turner Overton et al. PLoS One
- Human endogenous retroviruses and their implication for immunotherapeutics of cancer
- (2018) A S Attermann et al. ANNALS OF ONCOLOGY
- Tissue-resident memory CD8+ T cells promote melanoma–immune equilibrium in skin
- (2018) Simone L. Park et al. NATURE
- Intrinsic 4-1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung
- (2017) A C Zhou et al. Mucosal Immunology
- Enhanced anti-tumour immunity requires the interplay between resident and circulating memory CD8+ T cells
- (2017) Michel Enamorado et al. Nature Communications
- Induction of resident memory T cells enhances the efficacy of cancer vaccine
- (2017) Mevyn Nizard et al. Nature Communications
- Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation
- (2016) Peter Ellmark et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody
- (2016) Neil H. Segal et al. CLINICAL CANCER RESEARCH
- Deciphering CD137 (4-1BB) signaling in T-cell costimulation for translation into successful cancer immunotherapy
- (2016) Alfonso R. Sanchez-Paulete et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Intratumoral Delivery of Immunotherapy—Act Locally, Think Globally
- (2016) M. Angela Aznar et al. JOURNAL OF IMMUNOLOGY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity
- (2015) Todd Bartkowiak et al. Frontiers in Oncology
- PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
- (2014) Alena Gros et al. JOURNAL OF CLINICAL INVESTIGATION
- Cutting Edge: Resident Memory CD8 T Cells Occupy Frontline Niches in Secondary Lymphoid Organs
- (2014) J. M. Schenkel et al. JOURNAL OF IMMUNOLOGY
- Murine leukemia virus envelope gp70 is a shared biomarker for the high-sensitivity quantification of murine tumor burden
- (2014) Francesca Scrimieri et al. OncoImmunology
- Locally Delivered CD40 Agonist Antibody Accumulates in Secondary Lymphoid Organs and Eradicates Experimental Disseminated Bladder Cancer
- (2013) L. C. Sandin et al. Cancer Immunology Research
- Genetic Adjuvantation of Recombinant MVA with CD40L Potentiates CD8 T Cell Mediated Immunity
- (2013) Henning Lauterbach et al. Frontiers in Immunology
- Subcapsular sinus macrophages promote NK cell accumulation and activation in response to lymph-borne viral particles
- (2012) Z. Garcia et al. BLOOD
- Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell–mediated deletion
- (2012) Dimitra Peppa et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The HIF-1α Hypoxia Response in Tumor-Infiltrating T Lymphocytes Induces Functional CD137 (4-1BB) for Immunotherapy
- (2012) Asís Palazón et al. Cancer Discovery
- Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
- (2011) S.-R. Woo et al. CANCER RESEARCH
- Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity
- (2011) P. A. Lang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Synergistic anti-tumor effects between oncolytic vaccinia virus and paclitaxel are mediated by the IFN response and HMGB1
- (2010) B Huang et al. GENE THERAPY
- Immune Requirements of Post-Exposure Immunization with Modified Vaccinia Ankara of Lethally Infected Mice
- (2010) Henning Lauterbach et al. PLoS One
- Immune regulation by 4-1BB and 4-1BBL: complexities and challenges
- (2009) Chao Wang et al. IMMUNOLOGICAL REVIEWS
- Modified vaccinia Ankara strains with identical coding sequences actually represent complex mixtures of viruses that determine the biological properties of each strain
- (2009) Mark Suter et al. VACCINE
- Interleukin-15/Interleukin-15R Complexes Promote Destruction of Established Tumors by Reviving Tumor-Resident CD8+ T Cells
- (2008) M. Epardaud et al. CANCER RESEARCH
- Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection
- (2008) Christofer Samuelsson et al. JOURNAL OF CLINICAL INVESTIGATION
- Vaccinia Virus-Mediated Inhibition of Type I Interferon Responses Is a Multifactorial Process Involving the Soluble Type I Interferon Receptor B18 and Intracellular Components
- (2008) Z. Waibler et al. JOURNAL OF VIROLOGY
- Age-dependent tolerance to an endogenous tumor-associated antigen
- (2008) Jennifer A. McWilliams et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now